HK124397A - Terazosin polymorph and pharmaceutical composition - Google Patents
Terazosin polymorph and pharmaceutical compositionInfo
- Publication number
- HK124397A HK124397A HK124397A HK124397A HK124397A HK 124397 A HK124397 A HK 124397A HK 124397 A HK124397 A HK 124397A HK 124397 A HK124397 A HK 124397A HK 124397 A HK124397 A HK 124397A
- Authority
- HK
- Hong Kong
- Prior art keywords
- terazosin
- polymorph
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5491793A | 1993-04-29 | 1993-04-29 | |
US08/090,721 US5294615A (en) | 1993-04-29 | 1993-07-13 | Terazosin polymorph and pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
HK124397A true HK124397A (en) | 1997-09-12 |
Family
ID=26733641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK124397A HK124397A (en) | 1993-04-29 | 1997-06-26 | Terazosin polymorph and pharmaceutical composition |
Country Status (9)
Country | Link |
---|---|
US (2) | US5294615A (es) |
EP (1) | EP0623612B1 (es) |
JP (1) | JP2755895B2 (es) |
DE (1) | DE69300913T2 (es) |
DK (1) | DK0623612T3 (es) |
ES (1) | ES2089665T3 (es) |
GR (1) | GR3018433T3 (es) |
HK (1) | HK124397A (es) |
MX (1) | MX9306196A (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5596109A (en) * | 1992-03-24 | 1997-01-21 | Smithkline Beecham Corporation | N-t-butyl-androst-3,5-diene-17β-carboxamide-3-carboxylic acid polymorph A |
US5412095A (en) * | 1993-04-29 | 1995-05-02 | Abbott Laboratories | Terazosin monohydrochloride and processes and intermediate for its production |
JPH07206857A (ja) * | 1993-12-28 | 1995-08-08 | Synthelabo Sa | アルフゾシン塩酸塩の二水和物 |
US5504207A (en) * | 1994-10-18 | 1996-04-02 | Abbott Laboratories | Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
US5587377A (en) * | 1995-10-24 | 1996-12-24 | Invamed, Inc. | Terazosin crystalline polymorph and pharmaceutical compositions thereof |
DE19546573A1 (de) * | 1995-12-13 | 1997-06-19 | Uetikon Chemie Gmbh | Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung |
US5952003A (en) * | 1996-08-01 | 1999-09-14 | Novartis Corporation | Terazosin capsules |
IT1286790B1 (it) * | 1996-11-29 | 1998-07-17 | Alfa Chem Ital | Processo per la produzione della forma i del terazosin monocloridrato anidro |
IT1286789B1 (it) * | 1996-11-29 | 1998-07-17 | Alfa Chem Ital | Processo per la produzione della forma i del terazosin monocloridato anidro |
EP0849264A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von doxazosinmesylat (Form I) |
ATE353892T1 (de) * | 1996-12-20 | 2007-03-15 | Heumann Pharma Gmbh & Co | Neue polymorphe form von doxazosinmesylat (form iii) |
EP0849265A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
US6248888B1 (en) | 1997-11-14 | 2001-06-19 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of terazosin hydrochloride dihydrate |
KR20060093355A (ko) * | 1999-08-03 | 2006-08-24 | 릴리 아이코스 엘엘씨 | 베타-카르볼린 약학 조성물 |
US6200573B1 (en) | 1999-12-03 | 2001-03-13 | Starcor Pharmaceuticals, Inc. | Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia |
DE10000792A1 (de) * | 2000-01-11 | 2001-07-19 | Bernhard C Lippold | Formulierungen von Wirkstoffen in Form einer festen Dispersion |
ATE405577T1 (de) * | 2000-11-17 | 2008-09-15 | Lilly Co Eli | Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung |
US20030138483A1 (en) * | 2001-05-25 | 2003-07-24 | Sergio Petriconi | Soft elastic capsules and compositions thereof |
WO2003034961A1 (en) * | 2001-10-23 | 2003-05-01 | Euro-Celtique, S.A. | Terazosin transdermal device and methods |
IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
TWI353979B (en) | 2002-04-10 | 2011-12-11 | Nippon Zoki Pharmaceutical Co | Novel crystal form of 5-hydroxy-1-methylhydantoin |
US7097967B2 (en) * | 2002-10-24 | 2006-08-29 | Lg Life Sciences Ltd. | Method of predicting drug-food interaction |
KR20040076203A (ko) * | 2003-02-24 | 2004-08-31 | 주식회사 엘지생명과학 | 음식물-약물 상호작용을 방지하기 위한 경구 투여용약제학적 조성물 및 방법 |
WO2008021891A2 (en) * | 2006-08-08 | 2008-02-21 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
CN102321563B (zh) | 2011-10-24 | 2013-04-03 | 江南大学 | 一株拟无枝酸菌及利用其全细胞转化制备香草醛的方法 |
US9096428B2 (en) * | 2013-03-08 | 2015-08-04 | Taiwan Semiconductor Manufacturing Company, Ltd. | Methods and apparatus for MEMS structure release |
US11224572B1 (en) | 2020-08-17 | 2022-01-18 | Novitium Pharma LLC | Stable oral liquid composition of terazosin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
GB1591490A (en) * | 1977-08-04 | 1981-06-24 | Abbott Lab | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate |
US5122514A (en) * | 1990-04-23 | 1992-06-16 | Abbott Laboratories | Psoriasis treatment |
US5212176A (en) * | 1990-06-29 | 1993-05-18 | Abbott Laboratories | R(+)-terazosin |
JP2652272B2 (ja) * | 1990-12-31 | 1997-09-10 | 住化ファインケム株式会社 | 1−(4−アミノ−6,7−ジメトキシ−2−キナゾリニル)−4−(2−テトラヒドロフロイル)ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法 |
-
1993
- 1993-07-13 US US08/090,721 patent/US5294615A/en not_active Expired - Fee Related
- 1993-09-28 EP EP93115607A patent/EP0623612B1/en not_active Revoked
- 1993-09-28 DE DE69300913T patent/DE69300913T2/de not_active Revoked
- 1993-09-28 ES ES93115607T patent/ES2089665T3/es not_active Expired - Lifetime
- 1993-09-28 DK DK93115607.9T patent/DK0623612T3/da active
- 1993-10-05 MX MX9306196A patent/MX9306196A/es not_active IP Right Cessation
- 1993-10-14 JP JP5257010A patent/JP2755895B2/ja not_active Expired - Lifetime
-
1994
- 1994-01-06 US US08/178,184 patent/US5362730A/en not_active Expired - Fee Related
-
1995
- 1995-12-15 GR GR950403563T patent/GR3018433T3/el unknown
-
1997
- 1997-06-26 HK HK124397A patent/HK124397A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH06312984A (ja) | 1994-11-08 |
JP2755895B2 (ja) | 1998-05-25 |
EP0623612A1 (en) | 1994-11-09 |
DE69300913T2 (de) | 1996-05-02 |
MX9306196A (es) | 1994-01-31 |
ES2089665T3 (es) | 1996-10-01 |
DE69300913D1 (de) | 1996-01-11 |
DK0623612T3 (da) | 1996-02-05 |
EP0623612B1 (en) | 1995-11-29 |
GR3018433T3 (en) | 1996-03-31 |
US5362730A (en) | 1994-11-08 |
US5294615A (en) | 1994-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK124397A (en) | Terazosin polymorph and pharmaceutical composition | |
HU9402974D0 (en) | Pharmaceutical composition | |
ZA947305B (en) | Pharmaceutical compositions and usages | |
IL119078A (en) | Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them | |
GB9317686D0 (en) | Pharmaceutical compositions | |
IL110201A0 (en) | Novel pharmaceutical compositions | |
GB9317610D0 (en) | Pharmaceutical compositions | |
GB9316580D0 (en) | Pharmaceutical composition | |
GB2272375B (en) | Pharmaceutical composition | |
PL314036A1 (en) | Pharmaceutical composition | |
CA2100836A1 (en) | Pharmaceutical composition | |
GB9317504D0 (en) | Pharmaceutical compositions | |
ZA945752B (en) | Pharmaceutical composition | |
GB9318880D0 (en) | Pharmaceutical composition | |
HU9401771D0 (en) | Pharmaceutical compositions cintaining ipsapiron | |
ZA947878B (en) | Pharmaceutical compositions | |
GB9320688D0 (en) | Pharmaceutical composition | |
GB9314564D0 (en) | Pharmaceutical composition | |
GB9308849D0 (en) | Pharmaceutical composition | |
GB9314709D0 (en) | Pharmaceutical composition | |
HU9303511D0 (en) | Pharmaceutical composition | |
HU9303386D0 (en) | Pharmaceutical composition | |
GB9318350D0 (en) | Pharmaceutical composition | |
ZA947913B (en) | Pharmaceutical composition | |
ZA935269B (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |